You are here: Industry Insights > Alzheimer

News List

Can aspirin treat Alzheimer's? worldpharmanews
July 05, 2018
A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center, who published the results of their stud
Researchers identify brain metals that may precipitate Alzheimer’s pharmaceutical-technology
June 28, 2018
A research team including members from Warwick’s School of Engineering has identified and characterised certain brain metals that may precipitate the progression of Alzheimer’s disease.
'Big data' analysis links herpes virus to Alzheimer's development fiercebiotech
June 25, 2018
The idea that viruses might play a role in Alzheimer's disease is decades old but has never been definitively proven.
DDF, Immuneering form $1.3m Alzheimer’s research collaboration pharmatimes
June 21, 2018
Britain’s Dementia Discovery Fund has formed a research collaboration with US group Immuneering Corporation that aims to identify novel drug targets and candidates for Alzheimer's disease.
AstraZeneca, Eli Lilly scrap Alzheimer’s treatment trial financialexpress
June 14, 2018
AstraZeneca and Eli Lilly have announced the ending of a large clinical trial of treatment for Alzheimer’s that they had been developing together.
Study suggests some anticholinergic drugs linked with increased risk of developing dementia in older adults firstwordpharma
April 27, 2018
Results of a case-control study published in the BMJ found "a robust association" between some classes of anticholinergic drugs and an increased risk of developing dementia in the future in older adults.
Alzheimer’s protein treatment that works in human cells pharmafile
April 13, 2018
One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s disease, is that promising trials results in mice have not translated so successfully into human studies.
Antiepileptic drug use linked to increased risk of Alzheimer's and dementia pharmafile
April 11, 2018
A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases has revealed a link between antiepileptic drug use and an increased risk of developing Alzheimer’s disease and dementia.
vTv’s azeliragon is latest Alzheimer’s drug failure pharmaphorum
April 11, 2018
US biotech vTv Therapeutics has become the latest to fail in Alzheimer’s disease, after a phase 3 trial of azeliragon missed its two main goals.
Doctor Calls for Alzheimer’s Boot Camps to Spur Drug Development biospace
April 10, 2018
It’s no secret that drugmakers have struggled to develop a therapeutic to treat or halt the onset of Alzheimer’s disease.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page